|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Overview
Datamonitor, Feb 2011, Pages: 72
Introduction
Prescription pharmaceutical sales in the world’s major markets (US, France, Germany, Italy, Spain, the UK, Japan, Australia, Brazil, Russia, China and India) totaled $555bn in 2009, having grown by 6.3% during 2008–09, and at a compound annual growth rate (CAGR) of 5.6% between 2005 and 2009.
Features and benefits
- Examines the prescription pharmaceutical sales growth trends across the various different therapy areas
- Assesses the leading prescription pharmaceutical brands across the each of the 12 major pharma markets
- Profiles the leading multinational and domestic pharma companies operating in each of the 12 major pharma markets
- Analyzes the forecast sales according to lifecycle stage of drug, molecule type, source of drug, geographical market, therapy area and formulation
Highlights
- The US prescription pharmaceutical market generated half (50.3%) of the sales of the 12 markets analyzed, with $279bn in 2009, with sales having grown by 5.0% (CAGR, 2005–09) and 5.5% (2008–09). However, future sales growth will be shaped by three key events: the US economic downturn, healthcare reform and the patent cliff.
- Pharma is set to loose approximately $108bn in sales due to the patent cliff during 2010–15, while the industry is also feeling the affect of the recent global economic downturn. However, Pharma is implementing a number of strategies to drive sales and profitability going forward: product innovation, diversification and cost-containment.
- Growth in the emerging markets is driven by their rapidly growing economies and populations; expansion of healthcare systems and health insurance policies, increasing access to drugs; and the emergence of middle classes with disposable incomes, who are more likely to spend money on branded generics and branded pharmaceuticals.
Your key questions answered
- Evaluate the evolving prescription pharmaceutical landscape and how this is set to impact Pharma out to 2015
- Quantify the size and growth of the 12 major pharmaceutical markets, analyzing key therapy areas, brands and companies
- Assess drivers and resistors of the prescription pharmaceutical market
|
|
|
|
